{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:24:41Z","timestamp":1791872681514,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12967-017-1331-4","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T08:54:09Z","timestamp":1509699249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment"],"prefix":"10.1186","volume":"15","author":[{"given":"Anette","family":"Hauge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine S.","family":"Wegner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon-Vidar","family":"Gaustad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trude G.","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Mari K.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar K.","family":"Rofstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"1331_CR1","unstructured":"National Cancer Institute (NIH). Cervical cancer treatment (PDQ\u00ae). http:\/\/www.cancer.gov\/types\/cervical\/hp\/cervical-treatment-pdq#section\/_126 . Accessed 3 Mar 2017."},{"key":"1331_CR2","first-page":"6400","volume":"61","author":"M Milosevic","year":"2001","unstructured":"Milosevic M, Fyles A, Hedley D, Pintilie M, Levin W, Manchul L, et al. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res. 2001;61:6400\u20135.","journal-title":"Cancer Res"},{"key":"1331_CR3","first-page":"916","volume":"60","author":"S Walenta","year":"2000","unstructured":"Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfor K, Rofstad EK, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60:916\u201321.","journal-title":"Cancer Res"},{"key":"1331_CR4","first-page":"4509","volume":"56","author":"M Hockel","year":"1996","unstructured":"Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56:4509\u201315.","journal-title":"Cancer Res"},{"key":"1331_CR5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0167-8140(99)00175-9","volume":"54","author":"K Sundfor","year":"2000","unstructured":"Sundfor K, Lyng H, Trope CG, Rofstad EK. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol. 2000;54:101\u20137.","journal-title":"Radiother Oncol"},{"key":"1331_CR6","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/bjc.1998.586","volume":"78","author":"K Sundfor","year":"1998","unstructured":"Sundfor K, Lyng H, Rofstad EK. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer. 1998;78:822\u20137.","journal-title":"Br J Cancer"},{"key":"1331_CR7","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.bjc.6600315","volume":"86","author":"J Hasan","year":"2002","unstructured":"Hasan J, Byers R, Jayson GC. Intra-tumoural microvessel density in human solid tumours. Br J Cancer. 2002;86:1566\u201377.","journal-title":"Br J Cancer"},{"key":"1331_CR8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.neo.2014.07.003","volume":"16","author":"EK Rofstad","year":"2014","unstructured":"Rofstad EK, Galappathi K, Mathiesen BS. Tumor interstitial fluid pressure\u2014a link between tumor hypoxia, microvascular density, and lymph node metastasis. Neoplasia. 2014;16:586\u201394.","journal-title":"Neoplasia"},{"key":"1331_CR9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ijrobp.2008.10.062","volume":"73","author":"C Ellingsen","year":"2009","unstructured":"Ellingsen C, Egeland TA, Gulliksrud K, Gaustad JV, Mathiesen B, Rofstad EK. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2009;73:838\u201345.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1331_CR10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.radonc.2013.10.018","volume":"110","author":"C Ellingsen","year":"2014","unstructured":"Ellingsen C, Hompland T, Galappathi K, Mathiesen B, Rofstad EK. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts. Radiother Oncol. 2014;110:335\u201341.","journal-title":"Radiother Oncol"},{"key":"1331_CR11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1593\/tlo.13313","volume":"6","author":"C Ellingsen","year":"2013","unstructured":"Ellingsen C, Walenta S, Hompland T, Mueller-Klieser W, Rofstad EK. The microenvironment of cervical carcinoma xenografts: associations with lymph node metastasis and its assessment by DCE-MRI. Transl Oncol. 2013;6:607\u201317.","journal-title":"Transl Oncol"},{"key":"1331_CR12","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1158\/0008-5472.CAN-12-0903","volume":"72","author":"T Hompland","year":"2012","unstructured":"Hompland T, Ellingsen C, Ovrebo KM, Rofstad EK. Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI. Cancer Res. 2012;72:4899\u2013908.","journal-title":"Cancer Res"},{"key":"1331_CR13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0360-3016(97)85090-0","volume":"36","author":"NA Mayr","year":"1996","unstructured":"Mayr NA, Yuh WT, Magnotta VA, Ehrhardt JC, Wheeler JA, Sorosky JI, et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int J Radiat Oncol Biol Phys. 1996;36:623\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1331_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0167-8140(00)00259-0","volume":"57","author":"RA Cooper","year":"2000","unstructured":"Cooper RA, Carrington BM, Loncaster JA, Todd SM, Davidson SE, Logue JP, et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol. 2000;57:53\u20139.","journal-title":"Radiother Oncol"},{"key":"1331_CR15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jmri.20795","volume":"25","author":"MA Haider","year":"2007","unstructured":"Haider MA, Sitartchouk I, Roberts TP, Fyles A, Hashmi AT, Milosevic M. Correlations between dynamic contrast-enhanced magnetic resonance imaging-derived measures of tumor microvasculature and interstitial fluid pressure in patients with cervical cancer. J Magn Reson Imaging. 2007;25:153\u20139.","journal-title":"J Magn Reson Imaging"},{"key":"1331_CR16","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1158\/1078-0432.CCR-12-2408","volume":"18","author":"S Kopetz","year":"2012","unstructured":"Kopetz S, Lemos R, Powis G. The promise of patient-derived xenografts: the best laid plans of mice and men. Clin Cancer Res. 2012;18:5160\u20132.","journal-title":"Clin Cancer Res"},{"key":"1331_CR17","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, Budinska E, Byrne AT, Caldas C, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014;4:998\u20131013.","journal-title":"Cancer Discov"},{"key":"1331_CR18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2016.01.047","volume":"373","author":"EK Rofstad","year":"2016","unstructured":"Rofstad EK, Simonsen TG, Huang R, Andersen LM, Galappathi K, Ellingsen C, et al. Patient-derived xenograft models of squamous cell carcinoma of the uterine cervix. Cancer Lett. 2016;373:147\u201355.","journal-title":"Cancer Lett"},{"key":"1331_CR19","doi-asserted-by":"crossref","first-page":"56986","DOI":"10.18632\/oncotarget.10931","volume":"7","author":"EK Rofstad","year":"2016","unstructured":"Rofstad EK, Huang R, Galappathi K, Andersen LM, Wegner CS, Hauge A, et al. Functional intratumoral lymphatics in patient-derived xenograft models of squamous cell carcinoma of the uterine cervix: implications for lymph node metastasis. Oncotarget. 2016;7:56986\u201397.","journal-title":"Oncotarget"},{"key":"1331_CR20","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1186\/s12885-015-1918-1","volume":"15","author":"JV Gaustad","year":"2015","unstructured":"Gaustad JV, Simonsen TG, Smistad R, Wegner CS, Andersen LM, Rofstad EK. Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging. BMC Cancer. 2015;15:900.","journal-title":"BMC Cancer"},{"key":"1331_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jmri.1880070113","volume":"7","author":"PS Tofts","year":"1997","unstructured":"Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997;7:91\u2013101.","journal-title":"J Magn Reson Imaging"},{"key":"1331_CR22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/mrm.20149","volume":"52","author":"IC Benjaminsen","year":"2004","unstructured":"Benjaminsen IC, Graff BA, Brurberg KG, Rofstad EK. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts. Magn Reson Med. 2004;52:269\u201376.","journal-title":"Magn Reson Med"},{"key":"1331_CR23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1080\/095530099139250","volume":"75","author":"EK Rofstad","year":"1999","unstructured":"Rofstad EK, Maseide K. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. Int J Radiat Biol. 1999;75:1377\u201393.","journal-title":"Int J Radiat Biol"},{"key":"1331_CR24","first-page":"9","volume":"147","author":"N Weidner","year":"1995","unstructured":"Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995;147:9\u201319.","journal-title":"Am J Pathol"},{"key":"1331_CR25","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1158\/1078-0432.CCR-06-1967","volume":"13","author":"EK Rofstad","year":"2007","unstructured":"Rofstad EK, Galappathi K, Mathiesen B, Ruud EB. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin Cancer Res. 2007;13:1971\u20138.","journal-title":"Clin Cancer Res"},{"key":"1331_CR26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mvr.2005.07.003","volume":"70","author":"U Ozerdem","year":"2005","unstructured":"Ozerdem U, Hargens AR. A simple method for measuring interstitial fluid pressure in cancer tissues. Microvasc Res. 2005;70:116\u201320.","journal-title":"Microvasc Res"},{"key":"1331_CR27","first-page":"4777","volume":"57","author":"H Hawighorst","year":"1997","unstructured":"Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Zuna I, Knof A, et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res. 1997;57:4777\u201386.","journal-title":"Cancer Res"},{"key":"1331_CR28","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ijrobp.2008.08.023","volume":"74","author":"MA Zahra","year":"2009","unstructured":"Zahra MA, Tan LT, Priest AN, Graves MJ, Arends M, Crawford RA, et al. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys. 2009;74:766\u201373.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1331_CR29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.radonc.2012.11.007","volume":"107","author":"EK Andersen","year":"2013","unstructured":"Andersen EK, Hole KH, Lund KV, Sundfor K, Kristensen GB, Lyng H, et al. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome. Radiother Oncol. 2013;107:117\u201322.","journal-title":"Radiother Oncol"},{"key":"1331_CR30","first-page":"3759","volume":"49","author":"F Kallinowski","year":"1989","unstructured":"Kallinowski F, Schlenger KH, Runkel S, Kloes M, Stohrer M, Okunieff P, et al. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res. 1989;49:3759\u201364.","journal-title":"Cancer Res"},{"key":"1331_CR31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrc3944","volume":"15","author":"S Aparicio","year":"2015","unstructured":"Aparicio S, Hidalgo M, Kung AL. Examining the utility of patient-derived xenograft mouse models. Nat Rev Cancer. 2015;15:311\u20136.","journal-title":"Nat Rev Cancer"},{"key":"1331_CR32","doi-asserted-by":"crossref","unstructured":"Litjens GJS, Heisen M, Buurman J, Romeny BMtH. Pharmacokinetic models in clinical practice: What model to use for DCE-MRI of the breast? In: 2010 IEEE international symposium on biomedical imaging: from nano to macro. 2010. p. 185\u20138.","DOI":"10.1109\/ISBI.2010.5490382"},{"key":"1331_CR33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12967-016-0920-y","volume":"14","author":"CS Wegner","year":"2016","unstructured":"Wegner CS, Gaustad JV, Andersen LM, Simonsen TG, Rofstad EK. Diffusion-weighted and dynamic contrast-enhanced MRI of pancreatic adenocarcinoma xenografts: associations with tumor differentiation and collagen content. J Transl Med. 2016;14:161.","journal-title":"J Transl Med"},{"key":"1331_CR34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/mrm.21367","volume":"58","author":"KG Brurberg","year":"2007","unstructured":"Brurberg KG, Benjaminsen IC, Dorum LM, Rofstad EK. Fluctuations in tumor blood perfusion assessed by dynamic contrast-enhanced MRI. Magn Reson Med. 2007;58:473\u201381.","journal-title":"Magn Reson Med"},{"key":"1331_CR35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/0284186X.2010.526633","volume":"50","author":"TA Egeland","year":"2011","unstructured":"Egeland TA, Gaustad JV, Galappathi K, Rofstad EK. Magnetic resonance imaging of tumor necrosis. Acta Oncol. 2011;50:427\u201334.","journal-title":"Acta Oncol"},{"key":"1331_CR36","first-page":"86","volume-title":"Radiobiology for the radiologist","author":"EJ Hall","year":"2012","unstructured":"Hall EJ, Giaccia AJ. Oxygen Effect and Reoxygenation. In: Mitchell CW, editor. Radiobiology for the radiologist. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 86\u2013103."},{"key":"1331_CR37","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.diii.2013.10.010","volume":"94","author":"CA Cuenod","year":"2013","unstructured":"Cuenod CA, Balvay D. Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. Diagn Interv Imaging. 2013;94:1187\u2013204.","journal-title":"Diagn Interv Imaging"},{"key":"1331_CR38","first-page":"140","volume":"58","author":"T Dunn","year":"1997","unstructured":"Dunn T. Oxygen and cancer. N C Med J. 1997;58:140\u20133.","journal-title":"N C Med J"},{"key":"1331_CR39","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin CH, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure\u2014an obstacle in cancer therapy. Nat Rev Cancer. 2004;4:806\u201313.","journal-title":"Nat Rev Cancer"},{"key":"1331_CR40","first-page":"5110","volume":"52","author":"Y Boucher","year":"1992","unstructured":"Boucher Y, Jain RK. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res. 1992;52:5110\u20134.","journal-title":"Cancer Res"},{"key":"1331_CR41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-chembioeng-061010-114300","volume":"2","author":"VP Chauhan","year":"2011","unstructured":"Chauhan VP, Stylianopoulos T, Boucher Y, Jain RK. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. Annu Rev Chem Biomol Eng. 2011;2:281\u201398.","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"1331_CR42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/mrm.23014","volume":"67","author":"TA Egeland","year":"2012","unstructured":"Egeland TA, Gulliksrud K, Gaustad JV, Mathiesen B, Rofstad EK. Dynamic contrast-enhanced-MRI of tumor hypoxia. Magn Reson Med. 2012;67:519\u201330.","journal-title":"Magn Reson Med"},{"key":"1331_CR43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.radonc.2011.11.013","volume":"102","author":"KM Ovrebo","year":"2012","unstructured":"Ovrebo KM, Hompland T, Mathiesen B, Rofstad EK. Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol. 2012;102:429\u201335.","journal-title":"Radiother Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-017-1331-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T10:45:28Z","timestamp":1570272328000},"score":1,"resource":{"primary":{"URL":"http:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-017-1331-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1186\/s12967-017-1331-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,3]]},"article-number":"225"}}